Diabetic Ketoacidosis
"Diabetic Ketoacidosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.
| Descriptor ID |
D016883
|
| MeSH Number(s) |
C18.452.076.176.652.500 C18.452.394.750.535 C19.246.099.812
|
| Concept/Terms |
Diabetic Ketoacidosis- Diabetic Ketoacidosis
- Diabetic Acidosis
- Ketoacidosis, Diabetic
- Diabetic Ketoacidoses
- Ketoacidoses, Diabetic
- Ketosis, Diabetic
- Acidosis, Diabetic
- Acidoses, Diabetic
- Diabetic Acidoses
- Diabetic Ketosis
- Diabetic Ketoses
- Ketoses, Diabetic
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Ketoacidosis".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Ketoacidosis".
This graph shows the total number of publications written about "Diabetic Ketoacidosis" by people in this website by year, and whether "Diabetic Ketoacidosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 1999 | 0 | 1 | 1 | | 2001 | 1 | 0 | 1 | | 2002 | 3 | 0 | 3 | | 2004 | 0 | 2 | 2 | | 2005 | 2 | 0 | 2 | | 2006 | 3 | 0 | 3 | | 2007 | 0 | 3 | 3 | | 2008 | 3 | 0 | 3 | | 2009 | 2 | 0 | 2 | | 2010 | 1 | 0 | 1 | | 2011 | 2 | 0 | 2 | | 2012 | 2 | 0 | 2 | | 2013 | 3 | 1 | 4 | | 2014 | 2 | 1 | 3 | | 2015 | 2 | 1 | 3 | | 2016 | 5 | 0 | 5 | | 2017 | 2 | 0 | 2 | | 2018 | 4 | 4 | 8 | | 2019 | 5 | 2 | 7 | | 2020 | 9 | 5 | 14 | | 2021 | 12 | 1 | 13 | | 2022 | 14 | 0 | 14 | | 2023 | 12 | 1 | 13 | | 2024 | 5 | 3 | 8 | | 2025 | 4 | 3 | 7 | | 2026 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Diabetic Ketoacidosis" by people in Profiles.
-
Denson AM, Rodriguez KE, Letourneau-Freiberg LR, Kandasamy B, Naylor RN, Abdullatif HD, Benjamin RW, Cobry E, Freemark MS, Thomas IH, Greeley SAW. Children With Pancreatic Hypoplasia Experience Poor Weight Gain and Labile Diabetes but Low Incidence of DKA. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):e1164-e1173.
-
Leiria G, McQueen RB, Jackson C, Rewers M, Hagopian WA, Oram RA, Fieldsend JE, Ferrat LA. Development of a Patient-Level Multi-objective Optimisation Model for Screening Strategies for Childhood Type 1 Diabetes. Pharmacoeconomics. 2026 Apr; 44(4):495-507.
-
Riddell MC, Parkin CG, Turner LV, Akturk HK. Potential Applications of Inhaled Insulin in Diabetic Ketoacidosis Prevention and During Exercise: Two Case Presentations. Diabetes Technol Ther. 2026 Feb; 28(1_suppl):31S-37S.
-
Sherr JL, Cobry EC. The Future of Dual Glucose-Ketone Monitoring in Youth with Diabetes. Diabetes Technol Ther. 2025 Nov; 27(S4):S36-S43.
-
Akturk HK, Perkins BA, Dunn TC. Clinical Trials in Diabetes: Examining the Value of Use of Continuous Dual Glucose-Ketone Monitoring. Diabetes Technol Ther. 2025 Nov; 27(S4):S44-S50.
-
Durnwald C, Polsky S. Continuous Dual Glucose-Ketone Monitoring. Diabetes Technol Ther. 2025 Nov; 27(S4):S51-S55.
-
Rewers M. Health economic considerations of screening for early type 1 diabetes. Diabetes Obes Metab. 2025 08; 27 Suppl 6:69-77.
-
Mahmud FH, Bjornstad P, Clarson C, Clarke A, Anthony SJ, Curtis J, Elia YT, McArthur L, Mertens L, Moineddin R, Kirsch S, Coles N, Maione M, Furman M, Babalola F, Tommerdahl KL, Harrington J, Riddell MC, Prasad P, Huang L, Heerspink HJL, Cherney DZI. Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial. Nat Med. 2025 Jul; 31(7):2317-2324.
-
Dovc K, Neuman V, Gita G, Cherubini V, Alonso GT, Fritsch M, Boettcher C, de Beaufort C, Holl RW, de Bock M. Association of Diabetic Ketoacidosis at Onset, Diabetes Technology Uptake, and Clinical Outcomes After 1 and 2 Years of Follow-up: A Collaborative Analysis of Pediatric Registries Involving 9,269 Children With Type 1 Diabetes From Nine Countries. Diabetes Care. 2025 Apr 01; 48(4):648-654.
-
Karakus KE, Fleury T, Baschal EE, McDaniel KA, Choi H, Armstrong TK, Yu L, Simmons KM, Michels AW. Clinical Features and HLA Genetics Differ in Children at Type 1 Diabetes Onset by Hispanic Ethnicity. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):1187-1194.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|